RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Clinical trial NCT06798896 · RECRUITING

Trial details

NCT number: NCT06798896
Sponsor: Supernus Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Onset Seizures

Start date: 2024-12-30
Primary completion: 2027-08-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.